Alzheimer's disease
Let an agent give accurate general information on Alzheimer's disease, recognise changes needing assessment, explain diagnosis, care and research with evidence, and point to specialist care and support for people and carers without individual medical advice.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent give accurate general information on Alzheimer's disease, recognise changes needing assessment, explain diagnosis, care and research with evidence, and point to specialist care and support for people and carers without individual medical advice.
A progressive neurodegenerative disease and the most common cause of dementia, characterised by accumulation of amyloid plaques and tau tangles in the brain, leading to memory loss, cognitive decline and changes in behaviour, usually in older age but with rarer early-onset and inherited forms; it is diagnosed by clinical assessment, imaging and biomarkers, and managed with supportive care and, increasingly, disease-modifying therapies.
What it is for: A neurodegenerative disease requiring diagnosis, care and support.
It can be explain the disease and its stages in general terms; recognise changes needing assessment; explain diagnosis, treatment and research; find specialist services and carer support.
Distinguishing features
Most common dementia
Amyloid and tau pathology
Progressive
Late and early-onset forms
What it looks like
Not physical; progressive memory and cognitive changes.
How it is recognised
Progressive memory loss and cognitive decline
Amyloid and tau pathology
Other dementias have different patterns and causes
Related models
is a kind of - category
is a kind of - category
is a - neurodegenerative disease
affects - organ
In practice
Families and kinds
late-onset Alzheimer's disease
early-onset Alzheimer's disease
inherited autosomal dominant forms
mixed dementia with vascular changes
preclinical and prodromal stages
Standards and regulation
Clinical guidelines from neurology and dementia bodies
Medicines regulation for disease-modifying therapies
Care standards and dementia strategies
Failure modes and hazards
Missing treatable causes of cognitive change
Agents diagnosing
Unproven treatments and scams targeting people with dementia
Also called
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Assess Changes to check.
Assessment first.
Signs
Warning changes.
Signs
Warning changes.
- Are there progressive memory or thinking changes that affect daily life and warrant assessment? boundary
- Should the person see a doctor for evaluation, including of treatable causes? action
Urgent
Urgent situations.
Urgent
Urgent situations.
- Is there sudden confusion, a wandering person at risk or another emergency? boundary
- Which service should be contacted now? action
Understand The disease.
General information.
Mechanism
What happens in the brain.
Mechanism
Mechanism.
- What is known about the causes and brain changes of Alzheimer's disease, according to research? provenance
- Is the user asking about their own diagnosis or test results? boundary
Risk
Risk and genetics.
Risk
Risk.
- What do health authorities say about risk factors, protective factors and inherited forms? provenance
- Who is eligible for genetic counselling? provenance
Care Treatment and support.
Evidence-based care.
Treatment
Care options.
Treatment
Care options.
- Which treatments and supportive care exist, in general terms, and what is the evidence for new disease-modifying therapies? provenance
- Which questions should be asked of the specialist? action
Unproven
Unproven treatments.
Unproven
Unproven treatments.
- Does this offered treatment or supplement have regulatory approval and evidence? boundary
- What do regulators warn about? provenance
Support People and carers.
Support for all.
Organisations
Support organisations.
Organisations
Support.
- Which organisations support people with Alzheimer's disease and their carers here? provenance
- Which planning tools, such as advance care planning, exist? provenance
Research
Research participation.
Research
Research.
- Which trials and registries are recruiting, according to registries? provenance
- How can someone discuss participation with their team? action
What the second pass must settle
- Should each form be a separate entry?
- How should guidelines be linked?
- How should support services be localised?